Zebra Capital Management LLC Organogenesis Holdings Inc. Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $4,531 - $7,791	-956 Reduced 2.85%	32,628 $159,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $89,583 - $132,506	13,846 Added 70.15%	33,584 $256,000
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $65,629 - $98,226	-7,276 Reduced 26.93%	19,738 $182,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $3,208 - $4,020	234 Added 0.87%	27,014 $385,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $43,163 - $67,204	-2,893 Reduced 9.75%	26,780 $445,000
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $217,503 - $624,913	29,673 New	29,673 $541,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.